The estimated Net Worth of Wenzhao Lu is at least $7.95 Миллион dollars as of 1 April 2020. Mr. Lu owns over 645,161 units of Avalon GloboCare Corp stock worth over $1,401,935 and over the last 8 years he sold AVCO stock worth over $2,500,000. In addition, he makes $4,047,220 as Chairman of the Board of Directors at Avalon GloboCare Corp.
Sign up
Mr. Wenzhao AVCO stock SEC Form 4 insiders trading
Lu has made over 4 trades of the Avalon GloboCare Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 645,161 units of AVCO stock worth $1,000,000 on 1 April 2020.
The largest trade he's ever made was selling 5,000,000 units of Avalon GloboCare Corp stock on 20 April 2017 worth over $2,500,000. On average, Lu trades about 710,145 units every 135 days since 2017. As of 1 April 2020 he still owns at least 2,645,161 units of Avalon GloboCare Corp stock.
You can see the complete history of Mr. Lu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lu Wenzhao biography
Lu Wenzhao serves as Chairman of the Board of Directors of the Company. He is a seasoned healthcare entrepreneur with extensive operational knowledge and experience in China. He has been serving as Chairman of the Board for the Daopei Medical Group, or DPMG, since 2010. Under his leadership, DPMG has recently expanded its clinical network involving a state-of-the-art stem cell bank at Wuhan Biolake, three top-ranked private hospitals (located in Beijing, Shanghai, and Hebei), specialty hematology laboratories, as well as a hematology research institute, with more than 100 partnering and collaborating hospitals in China. DPMG was founded by Professor Daopei Lu, a renowned hematologist pioneering in hematopoietic stem cell transplant and member of the Academy of Engineering in China. Mr. Wenzhao Lu received a Bachelor of Arts from Temple University Tyler School of Arts in 1988 and subsequently worked as senior Art Director at Ogilvy & Mather Advertising Company. Prior to joining DPMG, Mr. Lu served as Chief Operating Officer for BioTime Asia Limited, which is a subsidiary of BioTime, Inc. (NYSE American: BTX) in 2009. Mr. Lu is qualified to serve as a director because of his extensive operational knowledge of, and executive level management experience in, the healthcare industry.
What is the salary of Lu Wenzhao?
As the Chairman of the Board of Directors of Avalon GloboCare Corp, the total compensation of Lu Wenzhao at Avalon GloboCare Corp is $4,047,220. There are no executives at Avalon GloboCare Corp getting paid more.
How old is Lu Wenzhao?
Lu Wenzhao is 62, he's been the Chairman of the Board of Directors of Avalon GloboCare Corp since . There are 2 older and 10 younger executives at Avalon GloboCare Corp. The oldest executive at Avalon GloboCare Corp is Wilbert Tauzin, 76, who is the Director.
What's Lu Wenzhao's mailing address?
Wenzhao's mailing address filed with the SEC is C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD, NJ, 07728.
Insiders trading at Avalon GloboCare Corp
Over the last 8 years, insiders at Avalon GloboCare Corp have traded over $2,500,000 worth of Avalon GloboCare Corp stock and bought 898,876 units worth $1,418,962 . The most active insiders traders include Wenzhao Lu, Luisa Ingargiola и Steven Andrew Sanders. On average, Avalon GloboCare Corp executives and independent directors trade stock every 157 days with the average trade being worth of $446,629. The most recent stock trade was executed by Wenzhao Lu on 1 April 2020, trading 645,161 units of AVCO stock currently worth $1,000,000.
What does Avalon GloboCare Corp do?
Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
What does Avalon GloboCare Corp's logo look like?
Complete history of Mr. Lu stock trades at Avalon GloboCare Corp
Avalon GloboCare Corp executives and stock owners
Avalon GloboCare Corp executives and other stock owners filed with the SEC include:
-
Lu Wenzhao,
Chairman of the Board of Directors -
Luisa Ingargiola,
Chief Financial Officer -
David Jin,
President, Chief Executive Officer, Director -
Li Meng,
Chief Operating Officer, Secretary, Director -
Lu Yancen,
Independent Director -
Dr. David K. Jin M.D., Ph.D.,
CEO, Pres & Director -
Luisa Ingargiola,
Chief Financial Officer -
Meng Li,
COO, Sec. & Director -
Wilbert Tauzin,
Director -
William Stilley,
Independent Director -
Steven Sanders,
Independent Director -
Tevi Troy,
Independent Director -
Li Yue,
Independent Director -
Steven Philip Sukel,
Director